Lennox-Gastaut syndrome becomes second Epidyolex indication to be listed on PBS by Steve Jones June 5, 2023April 30, 2024 Epidyolex has been listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of Lennox-Gastaut Syndrome […]
Pharmacist who led Epidyolex launch opens emerging therapies dispensary by Steve Jones May 4, 2023April 30, 2024
Researchers to study effects of Epidyolex on patients with psychosis by Steve Jones February 17, 2023April 30, 2024
Bod says its softgel product could be the ‘benchmark delivery format’ for over-the-counter CBD by Martin Lane November 23, 2022April 29, 2024
Avecho study shows TPM formulation has ‘superior absorption to Epidyolex’ by Steve Jones September 19, 2022April 29, 2024
Company news: Emyria; Cann Group; Creso Pharma; Cronos; MGC Pharma by Martin Lane April 14, 2022April 29, 2024
Whole-plant cannabis may be more effective than conventional treatment in children with severe epilepsy by Hannah Adler December 17, 2021April 29, 2024
CBD may reduce adverse effects of anti-seizure medication for epilepsy patients by Hannah Adler August 12, 2021April 26, 2024
GW Pharmaceuticals receives UK approval for a new indication for Epidyolex by Hannah Adler August 11, 2021April 26, 2024
